bg
R

Relmada Therapeutics (RLMD)

$000.00 0.00% ($0.00)

  • اليوم
  • الأسبوع
  • الشهر
  • السنة
  • ٥ سنوات
  • حتى اليوم
barakagetbaraka.com

عن Relmada Therapeutics (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... اقرأ أكثر

  • USD4.45
  • USD4.47
  • USD4.25
  • USD5.12
  • 4.10%
  • --
  • 282.27k
  • 891.09k
  • 320M
  • 0.24
  • 853.50%

أخبار الأسهم